# Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/low-dose-apatinib-optimizes-tumor-microenvironment-and-potentiates-antitumor/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sha Zhao,Shengxiang Ren,Tao Jiang,Bo Zhu,Xuefei Li,Chao Zhao,Yijun Jia,Jinpeng Shi,Limin Zhang,Xiaozhen Liu,Meng Qiao,Xiaoxia Chen,Chunxia Su,Hui Yu,Caicun Zhou,Jun Zhang,D. Ross Camidge,Fred R. Hirsch |
| Citations | 336 |
| DOI | 10.1158/2326-6066.cir-17-0640 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2913818218 |
| PMID | 30755403 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Tao Jiang](https://scholariq.org/researchers/tao-jiang/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immune cells in cancer](https://scholariq.org/topics/immune-cells-in-cancer/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.